Home > Healthcare > Biotechnology > Bioservices > Upstream Bioprocessing Market
Upstream Bioprocessing Market Size
- Report ID: GMI8437
- Published Date: Mar 2024
- Report Format: PDF
Upstream Bioprocessing Market Size
Upstream Bioprocessing Market size was valued at USD 9.5 billion in 2023 and is anticipated to grow at CAGR of 9.7% from 2024 and 2032. One of the major factors contributing to the growth is the increasing demand for biopharmaceuticals caused by high prevalence of chronic diseases.
Therefore, the efficient and scalable upstream processes are essential to meet the growing demand for biopharmaceuticals & advanced therapies and address unmet medical needs. Further, the technological advancements such as single-use bioreactors, high-throughput screening, and bioreactor design, enhance productivity, efficiency, and scalability contributes to the increasing adoption of upstream bioprocessing.
Upstream bioprocessing refers to the initial stages of biotechnological production processes involved in manufacturing biological products such as pharmaceuticals, enzymes, or biofuels. It encompasses various steps from the selection and cultivation of host organisms (such as bacteria, yeast, or mammalian cells) to the preparation of the growth medium and the actual cultivation of these organisms in bioreactors or fermenters.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Upstream Bioprocessing Market Size in 2023: | USD 9.5 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 9.7% |
| 2032 Value Projection: | USD 21.6 Billion |
| Historical Data for: | 2018 - 2023 |
| No. of Pages: | 171 |
| Tables, Charts & Figures: | 301 |
| Segments covered: | Product, Usage Mode, Mode, Application, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Upstream Bioprocessing Market Scope
